Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Coll Radiol. 2008 Jan;5(1):53-6. doi: 10.1016/j.jacr.2007.08.012.

Impact on hospital policy: Yale experience.

Author information

1
Yale School of Medicine, New Haven, Connecticut 06520-8042, USA. jeffrey.weinreb@yale.edu

Abstract

To limit patients who may be at risk for nephrogenic systemic fibrosis from exposure to gadolinium-based magnetic resonance contrast agents, new policies and procedures have been implemented at Yale-New Haven Hospital. These changes include screening patients for low estimated glomerular filtration rates and risk factors for chronic kidney disease, giving increased attention to the types and doses of contrast agent administered, agreement on alternative imaging algorithms, and education at all levels of the medical community. The rationale for these changes is discussed.

PMID:
18180010
DOI:
10.1016/j.jacr.2007.08.012
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center